Shari Thomas

8 papers receiving 435 citations

Hit Papers

Safety and Efficacy of Pembrolizumab in Advanced, Programmed Death Ligand 1–Positive Cervical Cancer: Results From the Phase Ib KEYNOTE-028 Trial 2017 · 386 citations
3860+3+6Years since publication100200300

Peers

Shari Thomas
Comparison fields: 5 of 46
  • Obstetrics and Gynecology 143
  • Oncology 308
  • Reproductive Medicine 58
  • Immunology 134
  • Pathology and Forensic Medicine 55
Replace Cyril Abdeddaim with:
Cyril Abdeddaim France
Peter Widschwendter Germany
Eunice H. Rhee United States
David Shimizu United States
Oyeon Cho South Korea
Giulia Scaglione Italy
Nicoletta D’Alessandris Italy
Paolo Sala Italy
M. Lapresa Italy
Jennifer McLachlan United Kingdom
Shari Thomas relative to Cyril Abdeddaim France Cyril Abdeddaim's profile →
Citations per field
00.5×20×40×56×
Cyril Abdeddaim · 1×
Citations per year

Countries citing papers authored by Shari Thomas

Since Specialization
Citations

This map shows the geographic impact of Shari Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shari Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shari Thomas more than expected).

Fields of papers citing papers by Shari Thomas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shari Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shari Thomas. The network helps show where Shari Thomas may publish in the future.

Co-authors

The 25 scholars most cited alongside Shari Thomas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Shari Thomas Line = papers co-authored together Shari Thomas links everyone, so they are left out of the graph.

All Works

9 of 9 papers shown
#Work
1
Safety and Efficacy of Pembrolizumab in Advanced, Programmed Death Ligand 1–Positive Cervical Cancer: Results From the Phase Ib KEYNOTE-028 Trial
Hit paper breakdown →
2017386
2 201644
3 19894
4
Segmentation of Head from Ultrasound Fetal Image using Chamfer Matching and Hough Transform based Approaches
20143
5 20173
6 20221
7
Restoration of Hazy Videos using Dark Channel Approach and Guided Filtering
20141
8 19961
9 20250

About Shari Thomas

Shari Thomas is a scholar working on Oncology, Surgery, Computer Vision and Pattern Recognition, Epidemiology and Obstetrics and Gynecology, having authored 9 papers that have together received 443 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (2 papers), Endometrial and Cervical Cancer Treatments (2 papers), Antimicrobial Resistance in Staphylococcus (1 paper), Meningioma and schwannoma management (1 paper), Face recognition and analysis (1 paper), Cancer Research and Treatments (1 paper), Image and Signal Denoising Methods (1 paper) and Advanced Image Processing Techniques (1 paper). The work is most often cited by research in Obstetrics and Gynecology (143 citations), Oncology (308 citations), Reproductive Medicine (58 citations), Immunology (134 citations) and Pathology and Forensic Medicine (55 citations). Shari Thomas has collaborated with scholars based in United States, France and Netherlands. Frequent co-authors include Bert H. O’Neil, Sanatan Saraf, Patrick A. Ott, Andréa Varga, Sarina A. Piha‐Paul, Hope S. Rugo, Carlos Gomez‐Roca, Jean‐Sébastien Frenel, Christophe Le Tourneau and Emilie M.J. van Brummelen. Their work appears in journals such as Journal of Clinical Oncology, Menopause The Journal of The North American Menopause Society, Obstetrics and Gynecology Clinics of North America, Canada Communicable Disease Report and Orbit.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact